UnitedHealth Group shares closed at $378.81 in the latest trading session, rising 2.12% from the previous day. The move allowed the stock to outperform the broader market, with the S&P 500 gaining 0.6%, the Dow Jones Industrial Average adding 0.83%, and the Nasdaq Composite rising 0.64%. This performance contrasts with a recent trend in which UnitedHealth shares had lost 4.46% over the past month, a decline that lagged the Medical sector's loss of 1.97% and trailed the S&P 500's gain of 1.34% during the same period.
Investors are now focused on the company's upcoming earnings release, scheduled for October 13, 2026. Analysts predict UnitedHealth Group will post an earnings per share of $4.12 for that quarter, representing a 41.1% increase compared to the equivalent period last year. Revenue expectations are more modest, with the Zacks Consensus Estimate projecting net sales of $111.38 billion, a figure that is down 1.57% from the year-ago period.
For the full year, Zacks Consensus Estimates call for earnings of $19.85 per share and total revenue of $446.78 billion. These projections imply year-over-year changes of +21.41% for earnings and -0.18% for revenue. Recent shifts in analyst estimates have shown a slight positive trend, with the Zacks Consensus EPS estimate increasing by 0.15% over the last 30 days. Based on these revisions, UnitedHealth Group currently holds a Zacks Rank of #2 (Buy). The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has historically delivered an average annual gain of +25% for #1 stocks since 1988.
Valuation metrics suggest UnitedHealth Group is trading at a discount relative to its peers. The company holds a Forward P/E ratio of 18.69, which is lower than the industry average Forward P/E of 20.83. Additionally, UNH carries a PEG ratio of 1.39, identical to the average PEG ratio of the Medical - HMOs industry as of yesterday's trading close. The PEG ratio adjusts the P/E ratio to account for expected earnings growth.
The Medical - HMOs industry, part of the broader Medical sector, currently holds a Zacks Industry Rank of 43. This ranking places the industry within the top 18% of more than 250 tracked industries. Zacks research indicates that industries rated in the top 50% outperform those in the bottom half by a factor of 2 to 1.